Daniel Rosik
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 15
- Radiopharmaceutical Chemistry and Applications 5
-
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Vladimir Tolmachev (16 shared papers)Anna Orlova (14 shared papers)Mattias Sandström (7 shared papers)Anna Sjöberg (5 shared papers)Anders Wennborg (3 shared papers)Lars Abrahmsén (4 shared papers)Karl Andersson (3 shared papers)Fredrik Nilsson (2 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Bioconjugate Chemistry (4 papers)Journal of Nuclear Medicine (4 papers)Journal of Molecular Biology (1 paper)Cancer Research (1 paper)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
Daniel Rosik
16 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 47
- Radiology, Nuclear Medicine and Imaging 898
- Oncology 379
- Molecular Biology 407
- Biotechnology 43
- Immunology 66
Countries citing papers authored by Daniel Rosik
This map shows the geographic impact of Daniel Rosik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rosik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rosik more than expected).
Fields of papers citing papers by Daniel Rosik
This network shows the impact of papers produced by Daniel Rosik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rosik. The network helps show where Daniel Rosik may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rosik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 190 | |
| 2 | 2010 | 138 | |
| 3 | 2009 | 100 | |
| 4 | 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. | 2006 | 94 |
| 5 | 2009 | 92 | |
| 6 | 2007 | 85 | |
| 7 | 2012 | 82 | |
| 8 | 2013 | 80 | |
| 9 | 2011 | 61 | |
| 10 | 2013 | 47 | |
| 11 | 2009 | 44 | |
| 12 | Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors. | 2007 | 33 |
| 13 | 2013 | 28 | |
| 14 | 2013 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2011 | 12 | |
| 17 | Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA | 2012 | 0 |
About Daniel Rosik
Daniel Rosik is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology, Organic Chemistry and Pathology and Forensic Medicine, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Glycosylation and Glycoproteins Research (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Click Chemistry and Applications (1 paper), Galectins and Cancer Biology (1 paper), Photochromic and Fluorescence Chemistry (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (898 citations), Oncology (379 citations), Molecular Biology (407 citations), Biotechnology (43 citations) and Immunology (66 citations). Daniel Rosik has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Vladimir Tolmachev, Anna Orlova, Mattias Sandström, Anna Sjöberg, Anders Wennborg, Lars Abrahmsén, Karl Andersson, Fredrik Nilsson, Joakim Galli and Hans Lundqvist. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Bioconjugate Chemistry, Journal of Nuclear Medicine, Journal of Molecular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.